MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

    A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)

    Objective: To analyze the cognitive profile of patients with degenerative parkinsonian syndromes in the French West Indies and explore the correlations between cognitive deficits and…
  • 2019 International Congress

    Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

    D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

    Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…
  • 2019 International Congress

    Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

    R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To determine the frequency and impact of cognitive complaints in Parkinson’s disease (PD) patients with normal cognition (NC). Background: PD patients are at a…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients

    O. Monchi, JR. Sarna, D. Martino, Z. Gan-Or, JA. Ruskey, T. Alrazi, A. Robichaud, T. Hammer, ST. Lang, J. Cheetham, E. Yoon, M. Kibreab, I. Kathol, JS. Provost, M. Ramezani (Calgary, AB, Canada)

    Objective: To assess the effect of rs894280 of Sybnuclein-alpha (SNCA)gene on cognitive profile of idiopathic Parkinson’s disease (PD) patients and patterns of neuronal activity during a set-shifting…
  • 2019 International Congress

    Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

    TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

    Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…
  • 2019 International Congress

    Spoken Language Profiles in Parkinson’s Disease: A Potential ‘Biomarker’ of Cognitive Change?

    A. Roberts (Evanston, IL, USA)

    Objective: To Investigate the differences in spoken language profiles of individuals with Parkinson’s disease (PD) compared to healthy controls (HC). Background: In the absence of…
  • 2019 International Congress

    Measuring cognitive decline in PD-MCI patients with high level education: Do we have the appropriate tools?

    L. Mentzer, A. Richardson, T. Nevo, S. Meyer, S. Rosenblum, N. Gemerman, S. Hassin-Baer, S. Israeli-Korn, T. Fay-Karmon, V. Livneh, G. Yahalom (Ramat-Gan, Israel)

    Objective: To explore cognitive, neuropsychological and daily functional-related cognitive deficits among PD patients, diagnosed with mild cognitive impairment (MCI). Background: Level I diagnostic criteria for…
  • 2019 International Congress

    Praxis deficits in patients with Parkinson’s disease: A neuropsychological study

    E. Rounis, G. Pizzamiglio (Oxford, United Kingdom)

    Objective: 1. To identify presence and subtypes of apraxia in patients with idiopathic Parkinson’s Disease. 2. To relate praxis deficits in IPD to clinical UPDRS,…
  • 2019 International Congress

    The P3a wave and cognitive decline in relation to Parkinson’s disease severity

    G. Sánchez Dinorín, M. Rodríguez Violante, A. Cervantes Arriaga, C. Navarro Roa, R. Solís Vivanco (Mexico City, Mexico)

    Objective: To explore the association between the P3a wave, cognitive decline, and severity of Parkinson’s disease (PD). Background: It has been proposed that cognitive changes…
  • « Previous Page
  • 1
  • …
  • 1144
  • 1145
  • 1146
  • 1147
  • 1148
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley